Henry Schein, Inc. (HSIC) Receives Average Rating of “Hold” from Analysts
Shares of Henry Schein, Inc. (NASDAQ:HSIC) have received a consensus recommendation of “Hold” from the nineteen brokerages that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, eleven have assigned a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $91.81.
A number of equities research analysts have recently issued reports on the company. Stifel Nicolaus reiterated a “hold” rating on shares of Henry Schein in a research note on Thursday, July 6th. BidaskClub cut Henry Schein from a “hold” rating to a “sell” rating in a research note on Wednesday, August 2nd. Zacks Investment Research cut Henry Schein from a “buy” rating to a “hold” rating in a research note on Wednesday, August 9th. Piper Jaffray Companies upgraded Henry Schein from a “neutral” rating to an “overweight” rating in a research note on Friday, September 15th. Finally, UBS AG reiterated a “buy” rating on shares of Henry Schein in a research note on Friday, September 15th.
In other Henry Schein news, SVP Paul Rose sold 2,126 shares of the company’s stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total value of $366,756.26. Following the transaction, the senior vice president now directly owns 17,841 shares of the company’s stock, valued at approximately $3,077,750.91. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.27% of the company’s stock.
Large investors have recently added to or reduced their stakes in the company. YorkBridge Wealth Partners LLC lifted its position in shares of Henry Schein by 5.2% during the 2nd quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock valued at $104,000 after acquiring an additional 28 shares during the period. Sun Life Financial INC lifted its position in shares of Henry Schein by 8,185.7% during the 2nd quarter. Sun Life Financial INC now owns 580 shares of the company’s stock valued at $106,000 after acquiring an additional 573 shares during the period. Lee Financial Co bought a new stake in shares of Henry Schein during the 2nd quarter valued at $161,000. Westside Investment Management Inc. bought a new stake in shares of Henry Schein during the 1st quarter valued at $168,000. Finally, Acrospire Investment Management LLC lifted its position in shares of Henry Schein by 150.0% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,000 shares of the company’s stock valued at $183,000 after acquiring an additional 600 shares during the period. Hedge funds and other institutional investors own 44.56% of the company’s stock.
Henry Schein (NASDAQ HSIC) opened at 79.89 on Wednesday. Henry Schein has a 12 month low of $73.11 and a 12 month high of $93.50. The company has a market cap of $12.63 billion, a price-to-earnings ratio of 23.35 and a beta of 1.08. The company has a 50-day moving average of $83.22 and a 200-day moving average of $87.48.
Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, August 8th. The company reported $0.88 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.86 by $0.02. The firm had revenue of $3.06 billion for the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.82 EPS. Analysts predict that Henry Schein will post $3.64 EPS for the current year.
Henry Schein declared that its Board of Directors has approved a share repurchase plan on Monday, September 18th that permits the company to repurchase $400.00 million in outstanding shares. This repurchase authorization permits the company to purchase up to 6.3% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board of directors believes its stock is undervalued.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.